Skip to main content
All lobbying filings

FARRAGUT PARTNERS LLP

FARRAGUT PARTNERS LLP filed a Q3 report for JOHNSON & JOHNSON SERVICES INC on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for JOHNSON & JOHNSON SERVICES INC · ​Medical and consumers products

All filings by FARRAGUT PARTNERS LLP · Everything JOHNSON & JOHNSON SERVICES INC has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 7
  • JEFF MACKINNON
    Previously held: LD and LA Rep. Joe Barton (R-Texas)
  • JEFFERY C. MORTIER
    Previously held: Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes
  • SARAH WALTER
    Previously held: Former Legislative Director/Chief Counsel, Sen. John Breaux
  • EDWARD WHITFIELD
    Previously held: U.S. Representative (21 yrs.)
  • KRISTEN BAUTZ
    Previously held: Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz
  • DYLAN MOORE
    Previously held: Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); ; Intern, Rep. Mike Turner (OH-10)
  • CONSTANTINE HINGSON
    Previously held: Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation.

Health Issues

Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem